MedPath

Effects of Valerian on Prevention of Cognitive Impairment

Not Applicable
Conditions
Cognitive Impairment.
Other specified mental disorders due to brain damage and dysfunction and to physical disease
Registration Number
IRCT201311104190N2
Lead Sponsor
Vice chancellor for research, Islamic Azad University, Sari Branch
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

1.Patients aged between 30-70 years.
2.Coronary artery bypass surgery with cardiopulmonary bypass

Exclusion criteria:

1.Other simultaneous cardiac surgery (e.g., Valve replacement)
2.Symptomatic cerebrovascular disease
3.Alcoholism
4.Psychiatric illness (any clinical diagnosis requiring therapy)
5.Drug abuse
6.Hepatic insufficiency (liver function tests>1.5 times the upper limit of normal)
7.Severe pulmonary insufficiency (requiring home oxygen therapy)
8.Renal failure (serum creatinine>2mg/dl)
9.Reluctance to do a cognitive test performance
10.Previous heart surgery
11.Preoperative left ventricular ejection fraction<30%
12.Sensitivity to valerian

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognitive Impairment. Timepoint: Before intervention-ten days after beginning of intervention-two month after beginning of the intervention. Method of measurement: Mini Mental State Examination.
Secondary Outcome Measures
NameTimeMethod
Any reaction to valerian. Timepoint: Ten days after beginning of intervention-two month after beginning of the intervention. Method of measurement: Observation.
© Copyright 2025. All Rights Reserved by MedPath